XML 19 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (3,742,980) $ (1,951,226)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,183,104 1,108,797
Share-based compensation 212,975
Share-based consulting fees 36,769
Amortization of capitalized production costs 1,781,810
Impairment of goodwill 190,565
Allowance for credit losses 55,754 286,979
Change in fair value of warrants (5,000)
Change in fair value of convertible notes (70,000) (65,000)
Loss on extinguishment of debt 835,324
Deferred income tax expense, net 43,045 22,819
Debt origination costs amortization 7,012 8,411
Changes in operating assets and liabilities:    
Accounts receivable, trade and other (1,468,838) (1,739)
Other current assets (183,247) 94,371
Capitalized production costs (33,849) (24,766)
Other long-term assets and employee receivable (64,775) (112,000)
Deferred revenue 1,239,960 (600,306)
Accounts payable 822,295 (3,695,908)
Accrued interest – related parties 290,552 45,770
Other current liabilities 944,010 3,401,749
Other noncurrent liabilities (18,915)
Lease liability, operating leases (74,177) (121,485)
Lease liability, finance leases 38,203 47,654
Net cash (used in) provided by operating activities (197,522) 661,239
CASH FLOWS FROM INVESTING ACTIVITIES:    
    Purchase of fixed assets (1,088) (1,510)
Issuance of notes receivable (1,135,000)
Net cash used in investing activities (1,088) (1,136,510)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from convertible note payable 1,900,000
Proceeds from notes payable 550,000
Proceeds from related party loan 2,110,000
Proceeds from equity line of credit agreement 1,185,300
Repayment of term loan (833,977) (488,505)
Repayment of revolving line of credit (400,000)
Payment of contingent consideration (486,000)
Principal payments on finance leases (37,895) (45,280)
Net cash provided by financing activities 692,128 2,761,515
Net increase in cash and cash equivalents and restricted cash 493,518 2,286,244
Cash and cash equivalents and restricted cash, beginning of period 9,128,846 7,560,691
Cash and cash equivalents and restricted cash, end of period 9,622,364 9,846,935
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION:    
Interest paid 767,261 909,355
Lease liabilities arising from obtaining right-of-use assets 55,888 50,666
SUPPLEMENTAL DISCLOSURES OF NON-CASH FLOWS INFORMATION:    
Settlement of Special Projects working capital adjustment in shares of common stock 886,077
Cash and cash equivalents 8,697,360 8,718,975
Restricted cash 925,004 1,127,960
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows $ 9,622,364 $ 9,846,935